Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

The ASX200 has been up 0.25% at 8,505 points. Industrials has been the strongest performing sector, up 1.6%, followed by ...

News of a big and important regulator's move was the electricity that powered Biohaven (NYSE: BHVN) stock to an 11%-plus gain ...

Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering ...

Roxanne Lagano, Executive Vice President at Zoetis Inc . (NYSE:ZTS), recently executed a sale of company stock. According to a recent SEC filing, Lagano sold 326 shares of Zoetis common stock at a ...

Oncocyte Corp (NASDAQ:OCX), a small-cap biotechnology company with a market capitalization of $39.6 million, has reported that Patrick W. Smith, a significant shareholder of the company, has recently ...

Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...

In a challenging year for Actinium Pharmaceuticals (NYSE:ATNM), the company's stock has touched a 52-week low, trading at $1.1, marking an 80% decline from its 52-week high of $10.24. According to ...

Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.

Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.

SpringWorks Therapeutics (NASDAQ:SWTX), which is reportedly in takeover talks with Merck KGaA (OTCPK:MKGAF) (OTCPK:MKKGY), has received FDA approval for the drug mirdametinib for the treatment of ...

Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...